Caroline Vayne

Tours, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Corrigendum to 'Platelet dense granule defect: experience in the French population' [Research and Practice in Thrombosis and Haemostasis Volume 10, Issue 2, February 2026, 103364].

Corrigendum to 'Platelet dense granule defect: experience in the French population' [Research and Practice in Thrombosis and Haemostasis Volume 10, Issue 2, February 2026, 103364].

Journal: Research and practice in thrombosis and haemostasis

Published: July 28, 2026

Anti-PF4 antibodies trigger a faster and stronger platelet procoagulant response than anti-heparin/PF4 antibodies.

Anti-PF4 antibodies trigger a faster and stronger platelet procoagulant response than anti-heparin/PF4 antibodies.

Journal: Blood advances

Published: February 26, 2026

Platelet dense granule defect: experience in the French population.

Platelet dense granule defect: experience in the French population.

Journal: Research and practice in thrombosis and haemostasis

Published: December 21, 2025

Platelet Drp1 phosphorylation provides a platform for immune-based platelet function testing.

Platelet Drp1 phosphorylation provides a platform for immune-based platelet function testing.

Journal: Blood

Published: September 24, 2025

Platelet Drp1 phosphorylation provides a platform for immune-based platelet function testing.

Platelet Drp1 phosphorylation provides a platform for immune-based platelet function testing.

Journal: Blood

Published: September 24, 2025

Overview of practices among French clinical pathologists specialized in haemostasis

Overview of practices among French clinical pathologists specialized in haemostasis

Journal: Annales de biologie clinique

Published: March 27, 2025

Evaluation of 5B9 as a Calibrator or Expression of Results in Absorbance Values for the Diagnosis of Hit With a PF4/Heparin Specific Elisa.

Evaluation of 5B9 as a Calibrator or Expression of Results in Absorbance Values for the Diagnosis of Hit With a PF4/Heparin Specific Elisa.

Journal: International journal of laboratory hematology

Published: February 17, 2025

Cooperative effect between anti-PF4/H and anti-PF4 antibodies increases cell activation and thrombotic risk in HIT.

Cooperative effect between anti-PF4/H and anti-PF4 antibodies increases cell activation and thrombotic risk in HIT.

Journal: Blood advances

Published: October 17, 2024

A gain of function variant in RGS18 candidate for a familial mild bleeding syndrome.

A gain of function variant in RGS18 candidate for a familial mild bleeding syndrome.

Journal: Journal of thrombosis and haemostasis : JTH

Published: September 11, 2024

Imaging flow cytometry as a novel approach for the diagnosis of heparin-induced thrombocytopenia.

Imaging flow cytometry as a novel approach for the diagnosis of heparin-induced thrombocytopenia.

Journal: British journal of haematology

Published: September 07, 2024

G6b-B antibody-based cis-acting platelet receptor inhibitors (CAPRIs) as a new family of anti-thrombotic therapeutics.

G6b-B antibody-based cis-acting platelet receptor inhibitors (CAPRIs) as a new family of anti-thrombotic therapeutics.

Journal: bioRxiv : the preprint server for biology

Published: May 27, 2024

The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia.

The use of 1E12, a monoclonal anti-platelet factor 4 antibody, to improve the diagnosis of vaccine-induced immune thrombotic thrombocytopenia.

Journal: Journal of thrombosis and haemostasis : JTH

Published: December 14, 2023

Showing 1-12 of 41

Last Updated: 09/26/2026